← Back to BIIB

BIOGEN INC financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSSep 2026Filed 28/10/2026Jun 2026Filed 29/07/2026Mar 2026Filed 29/04/2026Sep 2025Filed 28/10/2026Jun 2025Filed 29/07/2026Mar 2025Filed 29/04/2026Sep 2024Filed 30/10/2025Jun 2024Filed 31/07/2025
$2,804$2,736$2,478$2,535$2,646$2,431$2,466$2,465
−$21$98$320$467$635$241$389$584
−$0.14$0.66$2.15$3.17$4.33$1.64$2.66$4.00
148149148147147147146146

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.